No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
143 |
4. Check minimum number of eventsNone |
143 |
5. Include endpointsNone |
143 |
6. Filter based on genotype QC (FinnGen only) |
143 |
Control definitions (FinnGen only)
- Control exclude
- G6_MYONEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G71
- Name in latin
- Myopathia mitochondrialis non alibi classificata
Similar endpoints
↥List of similar endpoints to
Mitochondrial myopathy
based on the number of shared cases.
Similar with more cases:
- Diseases of the myoneural junction and muscle
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 856 | 465 | 387 |
| Only index persons | 696 | 388 | 308 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 46.83 | 50.41 | 42.39 |
| Only index persons | 46.69 | 49.89 | 42.65 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 143 | 90 | 53 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | 48.15 | 47.84 | 48.66 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 130
- Matched controls
- 1300
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G71.3
ICD-10 Finland
Mitochondrial myopathy, not elsewhere classified
+∞
184.6
129
*
G72.9
ICD-10 Finland
Myopathy, unspecified
460.0
35.8
34
*
Z31.5
ICD-10 Finland
Genetic counselling
18.7
24.9
39
29
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
11.0
15.9
31
36
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
6.3
14.4
42
91
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
+∞
13.8
13
*
G72.8
ICD-10 Finland
Other specified myopathies
+∞
13.8
13
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
143.3
12.7
13
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
6.0
11.3
33
70
NXL00
NOMESCO Finland
Biopsy of muscle
119.2
10.6
11
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.8
10.6
27
48
R1250
NOMESCO Finland
Evaluation of functional capability
13.8
10.2
17
14
N99
ICPC
Neurological disease other
43.7
10.2
12
*
H02.4
ICD-10 Finland
Ptosis of eyelid
18.6
10.1
15
9
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
22.2
10.0
14
7
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
107.5
9.5
10
*
H49.4
ICD-10 Finland
Progressive external ophthalmoplegia
+∞
9.5
9
*
G71.08
ICD-10 Finland
Other muscular dystrophy
+∞
9.5
9
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.8
8.6
40
135
XCK00
NOMESCO Finland
Perimetry
8.0
8.6
19
27
L28
ICPC
Limited function/disability (L)
5.2
8.6
27
62
H53.2
ICD-10 Finland
Diplopia
14.1
8.6
14
11
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
+∞
8.4
8
*
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
35.8
8.2
10
*
R5120
NOMESCO Finland
Preparation of an aid
23.8
8.2
11
5
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
9.4
8.1
16
19
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
7.2
8.1
19
30
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
7.0
7.9
19
31
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
9.8
7.8
15
17
N03AX14
ATC
levetiracetam; systemic
26.8
7.7
10
*
XF404
NOMESCO Finland
Ambulatory ECG
5.0
7.5
24
56
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.8
7.5
25
61
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
84.7
7.5
8
*
C10AX09
ATC
ezetimibe; oral
4.9
7.4
24
57
N03AE01
ATC
clonazepam; systemic
6.4
7.4
19
34
G11.9
ICD-10 Finland
Hereditary ataxia, unspecified
+∞
7.4
7
*
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
32.0
7.2
9
*
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
32.0
7.2
9
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
32.0
7.2
9
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.7
7.2
33
109
N29
ICPC
Neurological sympt/complt other
42.3
6.8
8
*
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
42.3
6.8
8
*
N28
ICPC
Limited function/disability (N)
24.0
6.8
9
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.4
6.6
19
40
N03AF02
ATC
oxcarbazepine; oral
15.3
6.5
10
7
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.6
6.5
18
36
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.4
6.4
32
113
SPAT1215
SPAT
Assessment of need for medical rehabilitation
11.9
6.4
11
10
G71.8
ICD-10 Finland
Other primary disorders of muscles
+∞
6.3
6
*
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
+∞
6.3
6
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.8
6.3
17
33
A10AE04
ATC
insulin glargine; parenteral
4.8
6.3
20
47
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.6
6.2
29
97
G40.9
ICD-10 Finland
Epilepsy, unspecified
10.8
6.2
11
11
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
5.6
6.1
17
34
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
43
123
4.57
14.29
9.0
7.4
mmol/l
1.1
1.1
0.52
43
115
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
62
251
3.60
12.41
2.8
3.3
ng/l
2249.7
701.8
0.60
51
207
(3002032) Base excess in Venous blood by calculation
35
96
4.50
12.13
7.6
4.7
mmol/l
0.7
2.0
1.79
30
78
(3012544) pH of Venous blood
34
100
4.15
10.67
7.7
5.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
30
84
4.25
10.02
9.3
8.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
89
494
3.12
9.94
10.4
7.8
mmol/l
1.2
1.2
0.60
75
424
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
46
175
3.40
9.85
3.8
3.1
ng/l
289.4
131.6
0.34
35
118
(3019230) Fractional oxyhemoglobin in Venous blood
11
12
9.85
9.10
7.2
2.2
%
64.2
62.0
0.11
11
12
(3024928) Oxygen saturation in Venous blood
13
19
7.43
8.59
6.4
4.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
23
59
4.45
8.54
4.6
5.1
mmol/l
0.8
1.0
0.10
18
48
(3009508) Creatinine [Moles/volume] in Urine
61
297
2.84
8.30
4.7
3.3
mmol/l
6.1
7.6
1.64
55
254
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
80
454
2.73
8.01
12.0
6.6
mmol/l
1.2
1.2
0.08
75
420
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
20
50
4.49
7.64
6.5
2.2
%
1.0
1.4
0.83
20
50
(3044290) Cell count panel - Cerebral spinal fluid
13
25
5.62
6.62
1.0
2.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
51
4.14
6.61
1.4
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
51
255
2.55
6.30
5.5
3.0
mg/l
117.0
47.1
0.84
38
169
(3036481) Cortisol [Moles/volume] in Serum or Plasma
31
120
3.02
6.23
2.4
2.1
nmol/l
450.2
369.3
1.18
31
112
(3004588) Protein electrophoresis panel - Serum or Plasma
18
49
4.06
6.14
1.4
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
49
245
2.52
6.02
5.8
3.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
7
13.60
5.66
8.4
2.7
%
12.4
12.3
—
9
7
(3020682) Albumin/Creatinine [Ratio] in Urine
51
267
2.41
5.62
6.7
3.7
mg/mmol
23.5
7.4
1.15
35
173
(4035726)
26
99
2.99
5.34
1.6
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
34
150
2.66
5.33
1.8
1.7
nmol/l
1361.5
1182.3
0.40
26
108
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
36
4.20
5.12
1.1
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34
154
2.58
5.04
2.1
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
54
306
2.23
4.84
9.4
3.2
ph
7.4
7.4
—
10
49
(3016018) Differential panel - Cerebral spinal fluid
9
11
8.64
4.63
1.0
2.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
72
465
2.10
4.56
3.0
2.4
nmol/l
80.0
74.3
0.89
65
418
(3022313) Gas panel - Capillary blood
16
50
3.48
4.49
5.3
4.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
69
442
2.08
4.44
5.5
5.4
g/l
36.4
36.7
0.12
64
421
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
110
0.00
4.41
0.0
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
24
487
0.39
4.41
2.9
2.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
62
384
2.09
4.34
1.9
1.8
pmol/l
90.0
98.8
0.60
23
192
(3005719) IgG [Mass/volume] in Serum or Plasma
23
92
2.79
4.31
1.7
2.3
g/l
10.1
10.1
0.03
23
84
(3021901) Oxygen saturation in Capillary blood
9
16
5.92
3.72
1.6
5.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
17
63
2.93
3.64
10.6
6.9
mmol/l
23.5
25.0
0.72
17
63
(3028026) IgM [Mass/volume] in Serum or Plasma
18
69
2.84
3.63
1.3
1.7
g/l
1.2
1.1
0.14
18
63
(3037522) Nuclear Ab [Titer] in Serum
32
166
2.20
3.45
1.2
1.5
titre
330.0
460.5
—
8
37
(3027801) Oxygen [Partial pressure] in Arterial blood
22
99
2.44
3.26
5.8
12.9
kpa
11.8
11.8
0.01
22
93
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
22
99
2.44
3.26
5.8
12.9
kpa
4.9
5.2
0.46
22
93
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
56
363
1.89
3.26
5.3
3.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
96
1142
0.52
3.23
23.2
12.8
%
39.6
40.7
1.11
69
929
(4027681)
7
11
6.62
3.22
1.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
11
6.62
3.22
1.0
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
33
178
2.11
3.22
3.1
2.9
mmol/l
2.4
2.4
0.04
27
159
(3023410) Appearance of Cerebral spinal fluid
8
16
5.23
3.10
1.0
2.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
109
2.32
3.05
2.1
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
17
4.92
2.96
4.6
1.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
9
6.90
2.89
1.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
53
2.82
2.89
1.7
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
31
3.39
2.83
1.8
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
36
210
1.95
2.82
5.1
2.3
e6/l
6.8
4.8
0.32
31
187
(3021960) Folate [Moles/volume] in Serum or Plasma
37
219
1.93
2.78
1.6
1.4
nmol/l
21.2
21.9
0.07
32
185
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
14
5.20
2.76
1.0
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
9
24
3.93
2.72
1.8
1.0
g/l
0.0
0.0
—
9
24
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
13
49
2.82
2.70
5.0
3.0
%
52.2
53.7
0.09
13
49
(3020891) Body temperature
11
38
3.05
2.64
6.7
4.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
14
56
2.66
2.62
7.4
9.3
%
0.6
0.7
0.60
14
56
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
7
7.35
2.57
1.4
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
53
360
1.75
2.54
3.0
3.5
mmol/l
2.4
2.4
0.59
48
315
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
14
57
2.61
2.54
7.4
9.2
%
1.2
1.7
1.35
14
57
(3026008) Bacteria identified in Urine by Culture
45
292
1.79
2.52
3.0
2.6
—
—
—
0
0
(3026782) Osmolality of Urine
33
194
1.91
2.51
4.8
2.4
mosm/kgh2o
533.9
568.5
0.35
27
165
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
172
1.94
2.46
1.9
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
56
390
1.72
2.44
4.4
3.1
ng/l
47.2
25.0
0.70
44
233
(3007853) Bacteria identified in Skin by Aerobe culture
24
127
2.07
2.44
1.8
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
17
4.27
2.39
1.0
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
55
384
1.70
2.36
5.8
6.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
42
272
1.77
2.35
1.7
1.4
g/l
2.2
2.3
0.09
26
167
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
16
73
2.34
2.31
2.3
2.2
ug/l
7.9
4.9
0.71
16
65
(40760888) Immunoglobulin light chains.free panel - Serum
6
13
4.77
2.29
1.8
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
18
4.03
2.28
1.0
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
21
109
2.09
2.25
2.1
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
40
259
1.76
2.23
2.2
2.0
mg/l
3.4
0.9
0.44
28
202
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
25
3.33
2.13
1.3
1.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
19
97
2.11
2.12
1.9
2.6
—
6.2
—
0
5
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
10
5.14
2.09
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
26
3.20
2.04
2.6
2.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
45
2.56
1.98
8.1
19.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
27
3.08
1.97
1.1
1.0
—
—
—
0
0
(44806118)
5
11
4.67
1.95
1.0
2.2
—
—
—
0
0
(44790047)
5
11
4.67
1.95
1.0
2.2
—
—
—
0
0
(44790048)
5
11
4.67
1.95
1.0
2.2
—
—
—
0
0
(44790049)
5
11
4.67
1.95
1.0
2.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
44
303
1.65
1.94
1.5
1.3
u/ml
1.1
1.7
0.46
14
83
(3042936) Bacteria identified in Isolate by Culture
25
146
1.86
1.93
1.8
2.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
22
3.29
1.90
1.3
2.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
40
2.61
1.88
2.4
1.8
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
6
17
3.64
1.86
6.2
3.0
kpa
8.4
9.0
—
6
17
(3013290) Carbon dioxide [Partial pressure] in Blood
6
17
3.64
1.86
6.2
3.0
kpa
5.3
5.2
—
6
17
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
9
35
2.67
1.83
1.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
42
290
1.63
1.82
5.6
3.2
estimate
0.0
0.0
—
7
104
(21494755) Public health laboratory ask at order entry panel
7
163
0.40
1.81
1.0
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
46
327
1.60
1.77
5.5
3.0
e6/l
69.1
59.9
0.06
38
245
(3032080) INR in Blood by Coagulation assay
53
390
1.57
1.77
14.4
6.5
inr
1.1
1.1
0.31
15
114
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
18
3.43
1.76
8.7
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
24
3.01
1.74
1.0
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
13
3.94
1.73
1.0
1.6
—
—
—
0
0
(3019225) pH of Specimen
18
98
1.96
1.71
2.9
4.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
104
899
1.58
1.61
4.7
4.2
pmol/l
14.7
14.6
0.25
99
821
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
26
2.78
1.60
2.9
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
20
3.08
1.60
1.7
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
20
3.08
1.60
1.7
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
20
3.08
1.60
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
44
2.37
1.57
1.3
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
14
72
2.05
1.55
2.3
4.2
e9/l
75.7
71.8
—
9
55
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
15
3.41
1.53
1.0
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
40
284
1.57
1.53
5.6
7.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
45
0.00
1.53
0.0
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
21
2.94
1.52
1.2
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
21
2.94
1.52
1.7
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
55
421
1.50
1.49
4.8
3.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
127
1342
0.52
1.48
30.4
17.7
g/l
134.2
137.3
1.57
127
1325
(3010813) Leukocytes [#/volume] in Blood
127
1342
0.52
1.48
30.1
17.7
e9/l
6.9
6.6
1.62
127
1307
(3026361) Erythrocytes [#/volume] in Blood
127
1342
0.52
1.48
30.1
17.6
e12/l
4.5
4.6
0.98
127
1306
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
75
885
0.68
1.47
3.8
3.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
39
2.39
1.46
2.3
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
22
2.80
1.45
1.0
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
127
1341
0.53
1.44
30.0
17.6
fl
90.4
90.6
0.10
127
1325
(3035941) MCH [Entitic mass]
127
1341
0.53
1.44
30.0
17.5
pg
30.2
30.2
0.20
127
1325
(3037467) Urinalysis macro (dipstick) panel - Urine
90
766
1.47
1.40
5.9
3.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
127
1340
0.53
1.40
30.1
17.6
e9/l
268.4
256.7
1.22
127
1307
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
27
178
1.64
1.39
3.1
2.7
e6/l
0.7
0.8
0.14
18
90
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
17
3.01
1.37
1.4
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
37
0.00
1.36
0.0
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
42
2.22
1.36
1.8
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
26
171
1.64
1.35
3.2
2.8
e6/l
6.2
3.0
0.42
18
85
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
22
139
1.69
1.33
2.5
3.1
umol/l
6.6
6.2
0.07
17
116
(3011397) Hemoglobin [Presence] in Urine by Test strip
36
260
1.51
1.27
4.1
3.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
62
499
1.43
1.26
10.6
9.1
e9/l
0.0
0.0
0.00
54
395
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
11
56
2.04
1.26
1.3
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
19
2.69
1.22
1.2
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
19
2.69
1.22
6.2
3.4
nmol/l
3.9
2.9
—
5
19
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
11
57
2.01
1.20
2.1
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
20
127
1.67
1.19
6.0
6.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
34
0.00
1.17
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
34
0.00
1.17
0.0
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
50
392
1.42
1.16
6.6
3.6
e6/l
10.8
62.9
2.39
40
259
(3006184) Hemoglobin [Mass/volume] in Capillary blood
5
20
2.55
1.16
1.6
1.8
g/l
146.0
123.5
—
5
10
(3035637) Corticotropin [Mass/volume] in Plasma
5
20
2.55
1.16
1.2
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
11
58
1.97
1.15
3.6
12.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
21
2.43
1.10
1.8
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
36
268
1.46
1.09
2.8
2.6
umol/l
353.6
6075.9
1.30
29
230
(3015736) pH of Urine
55
444
1.39
1.07
4.2
3.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
38
289
1.43
1.03
5.5
2.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
48
1.93
1.02
1.7
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14
84
1.74
1.02
2.6
3.9
pmol/l
4.0
4.8
1.62
14
75
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
28
0.00
0.99
0.0
3.7
—
41.8
—
0
28
(3039443) Prostate specific Ag panel - Serum or Plasma
0
28
0.00
0.99
0.0
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
117
1079
1.46
0.96
5.7
4.8
mu/l
1.7
1.9
0.68
111
999
(36660697) Celiac disease serology panel - Serum
18
120
1.57
0.90
1.6
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
25
180
1.47
0.90
1.9
2.4
ug/g
71.4
96.0
0.41
20
144
(3030467) Casts [#/volume] in Urine by Automated count
37
290
1.37
0.84
5.6
3.0
e6/l
1.1
0.2
0.50
29
207
(40768443) Skin Pathology biopsy report
8
46
1.78
0.84
1.0
1.2
—
—
—
0
0
(3000492) Spirometry study
16
106
1.57
0.83
1.2
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
86
765
1.31
0.82
4.2
3.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
30
228
1.40
0.82
1.9
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
13
82
1.64
0.81
2.5
2.4
nmol/l
11.4
13.5
0.45
13
77
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
33
256
1.38
0.80
2.3
2.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
78
687
1.30
0.79
7.8
10.0
e9/l
4.2
4.0
0.48
78
601
(4010399)
13
83
1.62
0.78
1.5
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
34
1.80
0.77
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
34
1.80
0.77
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
34
1.80
0.77
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
34
1.80
0.77
1.2
1.4
—
—
—
0
0
(4306422)
5
23
2.21
0.77
1.2
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
64
551
1.29
0.76
5.1
3.2
estimate
0.0
0.0
—
9
103
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
100
1.56
0.76
1.2
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
17
117
1.51
0.76
1.8
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
124
1171
1.44
0.73
26.9
13.0
mmol/l
138.8
139.7
3.04
124
1144
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
5
26
1.96
0.71
3.2
1.6
—
93.9
—
0
5
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
26
1.96
0.71
3.2
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
26
1.96
0.71
1.2
2.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
26
1.96
0.71
1.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
69
1.64
0.70
4.0
2.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
42
1.70
0.69
1.6
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
78
1.59
0.68
1.1
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
94
1017
0.78
0.68
26.5
14.6
%
13.3
13.6
1.07
94
1002
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
28
1.81
0.67
4.6
4.7
g/l
3.3
3.5
—
5
28
(3023103) Potassium [Moles/volume] in Serum or Plasma
124
1177
1.40
0.65
27.2
13.0
mmol/l
4.0
3.9
2.88
124
1148
(3013512) EKG study
35
284
1.31
0.64
4.2
3.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
63
553
1.25
0.61
6.4
4.6
estimate
0.0
0.0
—
9
103
(46235355) HIV 1 and 2 tests - Meaningful Use set
33
267
1.31
0.61
2.2
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
20
0.00
0.61
0.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
52
1.57
0.60
1.3
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
22
0.00
0.60
0.0
2.0
—
13.5
—
0
22
(3003694) ABO and Rh group [Type] in Blood
25
314
0.75
0.59
1.4
1.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
35
1.74
0.58
4.3
4.2
%
206.2
189.1
—
6
35
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
45
1.58
0.49
3.0
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
45
511
0.83
0.45
4.2
4.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
79
1.43
0.42
4.2
3.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
4.1
—
111.7
—
0
15
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
14.2
—
1668.6
—
0
16
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
11.5
—
889.4
—
0
16
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
62
562
1.18
0.41
5.3
3.2
estimate
0.0
0.0
—
8
101
(3044640) Blood type and Crossmatch panel - Blood
39
339
1.21
0.40
2.5
2.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
71
1.44
0.40
1.4
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
68
1.34
0.38
1.2
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
68
1.34
0.38
1.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
68
1.34
0.38
1.2
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
168
0.75
0.38
1.3
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
69
1.32
0.38
1.2
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
90
1.36
0.37
5.3
3.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
114
1183
0.82
0.36
6.1
4.4
mmol/l
2.8
2.9
0.28
109
1107
(3025941) Bacteria identified in Stool by Culture
10
73
1.40
0.35
1.5
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
19
155
1.26
0.34
1.6
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
45
1.35
0.34
1.7
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
42
469
0.85
0.34
2.7
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
122
1256
0.80
0.34
20.0
10.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
46
1.32
0.33
1.7
2.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
53
1.34
0.31
2.3
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
113
1169
0.84
0.31
5.7
4.1
mmol/l
4.6
4.8
1.04
108
1103
(3041096) Erythrocytes [Presence] in Urine by Automated
35
310
1.17
0.30
5.0
2.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
63
1.29
0.28
1.3
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
16
192
0.81
0.27
3.1
4.0
%
23.6
19.8
—
9
80
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
95
1.29
0.27
1.3
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
114
1103
1.17
0.26
5.1
4.1
mmol/l
6.1
5.8
1.72
108
1032
(3023323) Follitropin [Units/volume] in Serum or Plasma
9
73
1.25
0.26
1.1
1.3
iu/l
25.8
23.0
—
9
62
(3001019) Free T4 and TSH panel - Serum or Plasma
6
85
0.69
0.24
1.7
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
117
1201
0.86
0.24
22.2
11.7
mg/l
26.0
20.4
0.67
98
889
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
199
0.83
0.23
2.4
2.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
12
146
0.81
0.23
1.8
1.8
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
8.3
—
0.6
—
0
11
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
2.0
—
0.2
—
0
5
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.5
—
2.1
—
0
10
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
12
0.00
0.21
0.0
1.8
—
32.6
—
0
12
(3035933) Granulocytes/100 leukocytes in Blood
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
21
238
0.86
0.20
1.3
1.5
—
—
—
0
0
(1002224) Polysomnography panel
5
68
0.73
0.17
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
265
1.12
0.16
1.5
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
106
1086
0.91
0.15
22.0
10.3
ml/min/173m2
87.0
87.2
0.02
95
874
(3000494) Fungus identified in Specimen by Culture
13
150
0.85
0.15
1.1
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
125
1270
0.87
0.15
13.2
9.8
u/l
34.0
26.8
3.04
125
1236
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
179
0.88
0.13
2.0
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
73
1.10
0.07
1.1
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
77
1.04
0.07
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
92
0.86
0.07
9.8
2.9
—
—
—
0
0
(3002256) Pathology report gross observation
15
138
1.10
0.06
1.4
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
20
210
0.94
0.04
1.2
1.3
u/ml
3.0
10.3
—
8
87
(40760892) CBC W Ordered Manual Differential panel - Blood
27
280
0.96
0.03
5.0
4.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
129
1.01
0.00
1.2
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
10.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(4198724)
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
10.9
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
105.8
—
0
6
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
9.3
—
0
5
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_MITOCMY and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MITOCMY | 4.998 [3.54, 7.06] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.267 |
During the follow-up period (1.1.1998 — 31.12.2019), 104 out of 373 females with G6_MITOCMY died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MITOCMY | 4.33 [2.96, 6.34] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 90 out of 317 males with G6_MITOCMY died.
Mortality risk
Mortality risk for people of age
years, who have G6_MITOCMY.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.585% | 0.899% |
| 5 | 3.166% | 5.188% |
| 10 | 7.96% | 12.612% |
| 15 | 13.614% | 22.547% |
| 20 | 22.641% | 35.342% |
Relationships between endpoints
↥Index endpoint: G6_MITOCMY – Mitochondrial myopathy
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data